Inquiries · Recommendations
Public Inquiry Recommendations
1,814 tracked recommendations
35 inquiries
682 match current filters
Page 6 of 14
Recommendations issued by UK statutory and non-statutory inquiries, with their tracked government response and supporting evidence.
Browse by inquiry
| Inquiry | Recs | Accepted |
|---|---|---|
| Mid Staffs Inquiry | 290 | 281 |
| Manchester Arena Inquiry | 169 | 169 |
| IICSA | 107 | 96 |
| Muckamore Abbey Inquiry | 106 | — |
| Grenfell Tower Inquiry | 104 | 104 |
| Infected Blood Inquiry | 103 | 102 |
| Hyponatraemia Inquiry | 96 | 96 |
| Fuller Inquiry | 92 | 71 |
| Leveson Inquiry | 92 | 77 |
| Vale of Leven Inquiry | 75 | 75 |
| Baha Mousa Inquiry | 73 | 72 |
| Southport Inquiry | 67 | — |
| RHI Inquiry | 45 | 44 |
| COVID-19 Inquiry | 44 | 24 |
| Morecambe Bay Investigation | 44 | 44 |
| Brook House Inquiry | 33 | 28 |
| Bichard Inquiry | 31 | 31 |
| Angiolini Inquiry | 30 | 29 |
| Post Office Horizon Inquiry | 27 | 25 |
| Jermaine Baker Inquiry | 26 | 22 |
| Edinburgh Tram Inquiry | 24 | 21 |
| Daniel Morgan Panel | 23 | 21 |
| Cranston Inquiry | 18 | — |
| Paterson Inquiry | 17 | 15 |
| HIA Inquiry | 12 | 12 |
| Scottish Hospitals Inquiry | 11 | 11 |
| Anthony Grainger Inquiry | 9 | 9 |
| Al-Sweady Inquiry | 9 | 9 |
| Hillsborough Panel | 9 | 5 |
| Fingerprint Inquiry | 9 | 9 |
| ICL Inquiry | 7 | 6 |
| Litvinenko Inquiry | 5 | 5 |
| Azelle Rodney Inquiry | 3 | 3 |
| Billy Wright Inquiry | 3 | 3 |
| Penrose Inquiry | 1 | 1 |
Recommendations
| Code | Recommendation | Inquiry | Response |
|---|---|---|---|
| AC-1c |
Legal Support Signposting
IBCA include a prominent reference to the availability of legal support paid by IBCA on all registration and application forms and in …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1d |
Three-Cohort Prioritisation
When IBCA opens up the service beyond people infected and registered with the support schemes, IBCA: (i) update the sequencing to three …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1e |
Oral Representations at Review
IBCA consider making provision, either generally or in specific cases, for oral representations to be made where a decision is reviewed internally, …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-1f |
Written Reasons for Decisions
Written reasons for the original decision must be provided so that the review process can operate fairly.
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2a |
Publish Guidance and Board Minutes
IBCA should publish: guidance, advice or instructions to claim managers; work undertaken by IBCA with the Cabinet Office's policy team to ensure …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2b |
Share Clinical Assessor Advice
In respect of any case in which the advice of a clinical assessor has been given, in relation to the person concerned …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2c |
Community Advisory Body
A formal role be given within IBCA for an advisory body consisting of people infected and affected, covering a range of experience …
|
Infected Blood Inquiry (2025) | Accepted |
| AC-2d |
Structured Response to Community Input
To build confidence that IBCA is actively listening to people infected and affected, IBCA adopt more of a structured response to contributions …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-2e |
Transparency of Scheme Design
The Government and IBCA establish a mechanism by which individuals or organisations may raise concerns which arise about any aspect of the …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-3a |
HIV Eligibility Start Date
An amendment to the Regulations be made as soon as possible to remove the reference to 1 January 1982 from Regulation 3.
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-4a |
Interferon Treatment Impacts
People infected with Hepatitis B or C who have received a course of treatment with or based on interferon should be recognised …
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-4b |
Special Category Mechanism
The Government reconsider whether to maintain its rejection in February 2025 of the recommendations of Sir Robert Francis KC and advice from …
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-4c |
Effective Treatment - Earnings Floor
For the calculation of Financial Loss awards for Hepatitis B, people born after 1953 should be treated like those born in or …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-4d |
Deeming of Severity Bands
Where the level of severity of a person's infection at Level 3 or more has been established to IBCA's satisfaction in relation …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-4e |
Evidence of Diagnosis Date
Regulation 14(2)(c) be amended to remove the requirement for evidence of the date of diagnosis of Hepatitis B or C. An appropriate …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-5a |
Severe Psychological Harm
The approach of the Infected Blood Psychology Service is adopted so that both a diagnosis made by a psychiatric professional and a …
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-6a |
Financial Loss and Care
"x" be removed from the equation set out in Regulation 7.
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-6b |
Exceptional Loss Evidence
The Cabinet Office consult on whether the evidential requirements for exceptional reduced earnings are likely to prove a barrier to people who …
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-7a |
Unethical Research Award
Where there is evidence that an individual was the victim of unethical research practices IBCA should be authorised to make an unethical …
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-7b |
Wider Definition of Unethical Research
When considering the evidence IBCA applies the wider definition of research explained in the Infected Blood Inquiry Additional Report chapter on Unethical …
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-7c |
Unethical Research Award Amount Review
The Minister consider whether the £10,000 (£15,000 for Treloar's pupils) should in justice be increased and further decides what sum he considers …
|
Infected Blood Inquiry (2025) | Under Consideration |
| IBI-A-8a |
Supplementary Route for Affected Persons
The Minister give consideration to there being a supplementary route for people affected. This could include opening the supplemental award for severe …
|
Infected Blood Inquiry (2025) | Accepted in Part |
| IBI-A-8b |
Affected Estates
The Regulations be amended such that where someone who would be an eligible affected person dies between 21 May 2024 and 31 …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-A-9a |
Bereaved Partner Support Scheme
The IBSS cut-off date of 31 March 2025 be reviewed, that the scheme should as soon as possible reinstate support payments to …
|
Infected Blood Inquiry (2025) | Accepted |
| IBI-1 |
Compensation Scheme
My principal recommendation remains that a compensation scheme should be set up now
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-2a |
UK and Devolved Memorials
A permanent memorial be established in the UK and consideration be given to memorials in each of Northern Ireland, Wales and Scotland. …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-2b |
Treloar's School Memorial
A memorial be established at public expense, dedicated specifically to the children infected at Treloar’s school. The memorial should be such as …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-2c |
Community Support Events
There should be at least three events, approximately six months apart, drawing together those infected and affected, the nature and timing of …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-3a |
Medical Education - Curriculum
The General Medical Council, and NHS Education for Scotland, Health Education and Improvement Wales, Northern Ireland Medical and Dental Training Agency and …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-3b |
Medical Education - Training Materials
They should look favourably upon putting together a package of training materials, with excerpts from oral and written testimony, to underpin what …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-3c |
Inquiry Website Preservation
The Inquiry website is maintained online
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4a(i) |
Duty of Candour - Northern Ireland
Duty of candour: A statutory duty of candour in healthcare should be introduced in Northern Ireland.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4a(ii) |
Duty of Candour - Scotland and Wales Review
Duty of candour: The operation of the duties of candour in healthcare in Scotland and in Wales should be reviewed, as it …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4a(iii) |
Duty of Candour - England Review
Duty of candour: The review of the duty of candour currently under way in England should be completed as soon as practicable.
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4a(iv) |
Individual Duty of Candour for Leaders
Statutory duty of candour: The statutory duties of candour in England, Scotland, Wales (and Northern Ireland, when introduced) should be extended to …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-4a(v) |
Leadership Accountability for Safety
Statutory duty of candour: Individuals in leadership positions should be required by the terms of their appointment and by secondary legislation to …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-4b |
Organisational Culture Change
Cultural Change: That a culture of defensiveness, lack of openness, failure to be forthcoming, and being dismissive of concerns about patient safety …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-4c(i) |
Simplify External Regulation
Regulation: That external regulation of safety in healthcare be simplified. As a first step towards this, there should be a UK wide …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4c(ii) |
Safety Management Systems Coordination
Regulation: That the national healthcare administrations in England, Northern Ireland, Scotland and Wales explore, and if appropriate, support the development and implementation …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4d |
Patient Records Audit
Patient Records: Before the end of 2027 there should be a formal audit, publicly reported, of the extent of success of digitisation …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-4e |
Cross-Administration Patient Safety Coordination
Coordination of patient records with devolved governments: Consideration should be given by the national healthcare administrations in England, Scotland, Wales and Northern …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-5a |
Civil Service Statutory Duty of Candour
The Government should reconsider whether, in the light of the facts revealed by this Inquiry, it is sufficient to continue to rely …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-5b |
Monitoring Non-Statutory Duties
If, on review, the Government considers that it is sufficient to rely on the current non-statutory duties in the Civil Service Code, …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-5c |
Ministerial Duty of Candour
The Government should consider the extent to which Ministers should be subject to a duty beyond their current duty to Parliament under …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-6a(i) |
Hepatologist Oversight and Fibroscan Access
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have been …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-6a(ii) |
Specialist Hepatology Centre Access
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have fibrosis …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-6a(iii) |
Uncertainty About Fibrosis
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Where there is any …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-6a(iv) |
Fibroscan for Liver Imaging
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Fibroscan technology should be …
|
Infected Blood Inquiry (2024) | Accepted |
| IBI-6a(v) |
Consultant Hepatologist Access
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those who have had …
|
Infected Blood Inquiry (2024) | Accepted in Part |
| IBI-6a(vi) |
Commissioning Hepatology Services
All patients who have contracted hepatitis via a blood transfusion or blood products should receive the following care: Those bodies responsible for …
|
Infected Blood Inquiry (2024) | Accepted |